Rare diseases
Investigational molecules
Locations
Back to Slovakia25 clinical trials in Stare Mesto, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaStudy on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder
SlovakiaStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
SlovakiaStudy on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment
SlovakiaStudy of Danicopan for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration
SlovakiaStudy of Batoclimab for Treating Patients with Active Thyroid Eye Disease
SlovakiaStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
SlovakiaStudy on Batoclimab for Patients with Thyroid Eye Disease
SlovakiaStudy of LY3502970 for Adults with Obesity or Overweight and Related Health Issues
SlovakiaEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
SlovakiaStudy on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on obesity and cardiovascular health, evaluating innovative treatments for weight management and cardiovascular disease prevention.
Several trials are investigating novel compounds like survodutide and orforglipron for weight reduction and metabolic improvement.
Comprehensive research into multiple sclerosis and migraine treatments, exploring new therapeutic approaches for neurological conditions.
Studies include evaluations of atogepant for migraine treatment and frexalimab for multiple sclerosis therapy.
Innovative research addressing Major Depressive Disorder and schizophrenia, testing new therapeutic combinations and treatment approaches.
Trials include testing seltorexant and aticaprant as adjunctive therapies for depression.
Specialized studies examining Thyroid Eye Disease and Sjögren's Syndrome, with focus on innovative biological treatments.
Research includes batoclimab trials for TED and danicopan studies for macular degeneration.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
